Skip to content
Home/Companies/Healthcare/OTB und rehability
OTB und rehability

OTB und rehability

Healthcare·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns OTB und rehability?

OTB und rehability is currently owned by Serafin Unternehmensgruppe through Serafin Evergreen Holding (2010 vintage), since 2024.

Hand-verified · updated 2026-07-03

Serafin Unternehmensgruppe
Investor
Serafin Unternehmensgruppe
Serafin Evergreen Holding · 2010 · Evergreen

Key facts

HQGermany
SectorHealthcare
StatusActive
Websitewww.rehability.de

More from Serafin Evergreen Holding

Other portfolio companies in the same fund.

Jaeger Group (Schrauben-Jaeger)
Jaeger Group (Schrauben-Jaeger)
Active
Business ServicesGermany· 2023
Exolon Group
Active
IndustrialsBelgium· 2020
RCR Industrial Flooring
RCR Industrial Flooring
Active
IndustrialsSpain· 2019
Bama
Exited 2023
ConsumerGermany· 2018
to
WESO-Aurorahuette
Exited 2020
IndustrialsGermany· 2018
to
BHS tabletop
BHS tabletop
Active
ConsumerGermany· 2017

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track OTB und rehability

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy OTB und rehability?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on OTB und rehability.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue